SUBSCRIBE
SUBSCRIBE
News   Deals

Daiichi Sankyo Co Ltd. Wins Approval to Buy Ranbaxy Laboratories After Hurdles

August 6, 2008 | 
1 min read
Aug. 5 (Bloomberg) -- Daiichi Sankyo Co., Japan's third- largest drugmaker, won approval from the Indian government to buy Ranbaxy Laboratories Ltd. for as much as $4.7 billion after overcoming regulatory hurdles that delayed the takeover.
Mergers & acquisitions Asia
Daiichi Sankyo
MORE ON THIS TOPIC
shopping cart loaded with pills with dollar signs around it on a light blue background
GLP-1
Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot
August 18, 2025
 · 
1 min read
 · 
Annalee Armstrong
C-suite
Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor
August 12, 2025
 · 
7 min read
 · 
Annalee Armstrong
Bayer office in Basel, Switzerland
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
August 12, 2025
 · 
2 min read
 · 
Tristan Manalac
A contemporary art collage depicting a giant ear listening to a message bubble while covering it with a hand. The concept of taking in a useful experience or overhearing a new idea.
Mergers & acquisitions
Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity
August 7, 2025
 · 
2 min read
 · 
Tristan Manalac